Brought to you by 
Resolve Therapeutics raises $2mm through Series A round
01 Mar 2013
Executive Summary
Resolve Therapeutics LLC (autoimmune diseases) brought in $2mm from New Science Ventures and Easton Capital (which each join the board of directors) in its Series A round. The company expects an additional $500k and a corporate investor to close out the round within a year.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Resolve Therapeutics raises $2mm through Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice